Please provide your email address to receive an email when new articles are posted on . Monthly seizure frequency percentage reduction was 68.73% for the entire study cohort. For those followed up in ...
Antiseizure medications help the majority of people with focal epilepsy, a common form of the neurological disorder. Yet most will still have episodes for at least a year after their treatment begins, ...
Longitudinal data suggested that treatment-resistant focal epilepsy may improve over time. Nearly 70% had reduced seizure frequency and some patients achieved seizure freedom. Improvement was not ...
MedPage Today on MSN
Novel agent reduces seizures in treatment-resistant epilepsy
Adjunctive azetukalner cut monthly focal onset seizure frequency by 53% in phase III study ...
About one-third of patients with focal epilepsy, a common form of the neurological disorder, are believed to respond poorly to available therapies. Yet they too may eventually see improvement, if not ...
Epilepsy is a common neurological disorder that affects millions of people worldwide. Characterized primarily by seizures, epilepsy can present in a variety of ways depending on the individual and the ...
Suicidality at the time of a focal epilepsy diagnosis was associated with a higher risk for future treatment resistance to antiseizure medications (ASMs), independent of concurrent mood or anxiety ...
LEIDEN, NETHERLANDS, February 6, 2026 /EINPresswire.com/ — CREATe Therapeutics (CREATe Tx) today announced a major breakthrough demonstrating complete prevention of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results